Clinical Trial Update: Effect of Opicapone at Steady State on Warfarin Pharmacokinetics [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates whether steady-state opicapone alters the pharmacokinetics of warfarin in individuals with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• OpiCapone
• Warfarin (warfarin)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED